---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-052152"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2026-08-04T11:13:54+00:00"
generated_at: "2026-08-04T11:15:14.395778+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Strata Critical Medical Q2 revenue $72.5M (+60.7% YoY); net loss $(10.5)M

## Summary
- Revenue $72.5M, up 60.7% YoY; Clinical segment contributed $24.3M vs. zero in prior year.
- Net loss from continuing ops $(10.5)M (14.5% of revenue) vs. $(3.4)M loss a year ago.
- Adjusted EBITDA $7.9M (10.9% margin); operating cash flow $5.7M, free cash flow $2.9M.
- Completed bolt-on acquisitions of Louisville Perfusion, Heart/Lung Transplant Recovery, Ohio Valley Perfusion in Q2.
- Signed agreement to take over Statline's Transplant Center Organ Placement customer relationships over next year.

## SEC filing metadata
- accession: 0001628280-26-052152
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2026-08-04T11:13:54+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000162828026052152/0001628280-26-052152-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000162828026052152/srta-20260804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-052152
- JSON: https://secwatch.observer/filing/0001628280-26-052152.json
- Plain text: https://secwatch.observer/filing/0001628280-26-052152.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.